OTCMKTS:CRGS - Curaegis Technologies Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.1990 0.00 (0.00 %) (As of 03/22/2019 04:00 PM ET)Previous Close$0.1990Today's Range$0.16 - $0.199052-Week Range$0.10 - $0.49Volume6,800 shsAverage Volume9,747 shsMarket Capitalization$10.03 millionP/E RatioN/ADividend YieldN/ABeta-0.56 ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email CurAegis Technologies, Inc. develops and markets advanced technologies in the areas of power, safety, and wellness. The company operates through two segments, CURA and Aegis. It focuses on the commercialization of various technologies, including myCadian watch, a wearable device, which is used to predict and detect the degradation of alertness in a user, and reveal sleep and fatigue problems; Z-Coach, an e-learning tool that offers sleep training and education solutions to correct sleep issues and enhance overall wellness; and hydraulic pumps for off road diesel engines. The company was formerly known as Torvec, Inc. and changed its name to CurAegis Technologies, Inc. in June 2016. CurAegis Technologies, Inc. was founded in 1996 and is headquartered in Rochester, New York. Receive CRGS News and Ratings via Email Sign-up to receive the latest news and ratings for CRGS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Motor vehicle parts & accessories Sub-IndustryN/A SectorBusiness Services Current SymbolOTCMKTS:CRGS Previous SymbolOTCMKTS:TOVC CUSIPN/A CIK1063197 Webwww.curaegis.com Phone585-254-1100Debt Debt-to-Equity RatioN/A Current Ratio0.07 Quick Ratio0.07Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$40,000.00 Price / Sales250.74 Cash FlowN/A Price / Cash FlowN/A Book Value($0.08) per share Price / Book-2.49Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-5,420,000.00 Net Margins-16,002.38% Return on EquityN/A Return on Assets-408.57%Miscellaneous Employees24 Outstanding Shares50,400,000Market Cap$10.03 million Next Earnings Date3/29/2019 (Estimated) OptionableNot Optionable Curaegis Technologies (OTCMKTS:CRGS) Frequently Asked Questions What is Curaegis Technologies' stock symbol? Curaegis Technologies trades on the OTCMKTS under the ticker symbol "CRGS." When is Curaegis Technologies' next earnings date? Curaegis Technologies is scheduled to release their next quarterly earnings announcement on Friday, March 29th 2019. View Earnings Estimates for Curaegis Technologies. Has Curaegis Technologies been receiving favorable news coverage? Media coverage about CRGS stock has been trending somewhat negative on Saturday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Curaegis Technologies earned a daily sentiment score of -1.5 on InfoTrie's scale. They also gave headlines about the company a news buzz of 9.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. Who are some of Curaegis Technologies' key competitors? Some companies that are related to Curaegis Technologies include Regency Affiliates (RAFI), Adomani (ADOM), Puradyn Filter Technologies (PFTI), OmniTek Engineering (OMTK), ATC Venture Group (ATCV), China Zenix Auto International (ZX), Enerpulse Technologies (ENPT) and QF Liquidation (QTWWQ). What other stocks do shareholders of Curaegis Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Curaegis Technologies investors own include Allena Pharmaceuticals (ALNA), Micron Technology (MU), Ampliphi Biosciences (APHB), Aurora Cannabis (ACBFF), Fate Therapeutics (FATE), Wheeler Real Estate Investment Trust (WHLR), Veru (VERU), Mirati Therapeutics (MRTX), Ampio Pharmaceuticals (AMPE) and Aphria (APHQF). Who are Curaegis Technologies' key executives? Curaegis Technologies' management team includes the folowing people: Mr. Richard A. Kaplan, CEO & Exec. Director (Age 73)Ms. Kathleen A. Browne CPA, CFO, Principal Accounting Officer & Corp. Sec. (Age 63)Mr. Keith E. Gleasman, Co-Founder, Pres & Director (Age 72)Mr. Joseph P. McMahon, Sr. VP of Engineering & TechnologyMr. Richard B. Sullivan, Corp. Counsel How do I buy shares of Curaegis Technologies? Shares of CRGS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Curaegis Technologies' stock price today? One share of CRGS stock can currently be purchased for approximately $0.1990. How big of a company is Curaegis Technologies? Curaegis Technologies has a market capitalization of $10.03 million and generates $40,000.00 in revenue each year. Curaegis Technologies employs 24 workers across the globe. What is Curaegis Technologies' official website? The official website for Curaegis Technologies is http://www.curaegis.com. How can I contact Curaegis Technologies? Curaegis Technologies' mailing address is 1999 MOUNT READ BLVD. BUILDING 3, ROCHESTER NY, 14615. The company can be reached via phone at 585-254-1100 or via email at [email protected] MarketBeat Community Rating for Curaegis Technologies (OTCMKTS CRGS)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 40 (Vote Outperform)Underperform Votes: 38 (Vote Underperform)Total Votes: 78MarketBeat's community ratings are surveys of what our community members think about Curaegis Technologies and other stocks. Vote "Outperform" if you believe CRGS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRGS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/23/2019 by MarketBeat.com StaffFeatured Article: What is the NASDAQ?